NCT05771532

Brief Summary

The purpose of this study was to evaluate the effectiveness of the Gender-Sensitive -Sexual Health Education Program (GS-SHEP) in enhancing the sexual health of patients with gynecologic cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 26, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 26, 2018

Completed
4.2 years until next milestone

First Submitted

Initial submission to the registry

March 5, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 16, 2023

Completed
Last Updated

March 16, 2023

Status Verified

February 1, 2023

Enrollment Period

1.3 years

First QC Date

March 5, 2023

Last Update Submit

March 5, 2023

Conditions

Keywords

Sexual Self-efficacySexualityHealth EducationGender sensitivityTranstheoretical Model

Outcome Measures

Primary Outcomes (20)

  • Gynecological Cancer Sexual Knowledge

    The research project assessed changes in gynecological cancer sexual knowledge by Gynecological Cancer Sexual Knowledge(GCSKS) from baseline to 6 months after the intervention. Gynecological Cancer Sexual Knowledge was measured by a 23-item Gynecological Cancer Sexual Knowledge Scale (GCSKS). The GCSKS was designed to assess common conceptions about sexuality after gynecologic cancer treatment (Lee et al., 2020). The 23 items are statements about sexual health which cover four domains: 1) the basic concept of sex; 2) effects of gynecologic cancer treatment on sexual health; 3) effects of gynecologic cancer on sexual health; and 4) management of 0sexual problems. Statements are answered with true, false, or unknown; correct answers = 1; incorrect answers = 0. Total scores range from 0 to 23, with higher scores indicating better sexual knowledge.

    Data were collected at baseline.

  • Gynecological Cancer Sexual Knowledge

    The research project assessed changes in gynecological cancer sexual knowledge by Gynecological Cancer Sexual Knowledge(GCSKS) from baseline to 6 months after the intervention. Gynecological Cancer Sexual Knowledge was measured by a 23-item Gynecological Cancer Sexual Knowledge Scale (GCSKS). The GCSKS was designed to assess common conceptions about sexuality after gynecologic cancer treatment (Lee et al., 2020). The 23 items are statements about sexual health which cover four domains: 1) the basic concept of sex; 2) effects of gynecologic cancer treatment on sexual health; 3) effects of gynecologic cancer on sexual health; and 4) management of 0sexual problems. Statements are answered with true, false, or unknown; correct answers = 1; incorrect answers = 0. Total scores range from 0 to 23, with higher scores indicating better sexual knowledge.

    Data were collected at 1 week after intervention.

  • Gynecological Cancer Sexual Knowledge

    The research project assessed changes in gynecological cancer sexual knowledge by Gynecological Cancer Sexual Knowledge(GCSKS) from baseline to 6 months after the intervention. Gynecological Cancer Sexual Knowledge was measured by a 23-item Gynecological Cancer Sexual Knowledge Scale (GCSKS). The GCSKS was designed to assess common conceptions about sexuality after gynecologic cancer treatment (Lee et al., 2020). The 23 items are statements about sexual health which cover four domains: 1) the basic concept of sex; 2) effects of gynecologic cancer treatment on sexual health; 3) effects of gynecologic cancer on sexual health; and 4) management of 0sexual problems. Statements are answered with true, false, or unknown; correct answers = 1; incorrect answers = 0. Total scores range from 0 to 23, with higher scores indicating better sexual knowledge.

    Data were collected at 6 weeks after intervention.

  • Gynecological Cancer Sexual Knowledge

    The research project assessed changes in gynecological cancer sexual knowledge by Gynecological Cancer Sexual Knowledge(GCSKS) from baseline to 6 months after the intervention. Gynecological Cancer Sexual Knowledge was measured by a 23-item Gynecological Cancer Sexual Knowledge Scale (GCSKS). The GCSKS was designed to assess common conceptions about sexuality after gynecologic cancer treatment (Lee et al., 2020). The 23 items are statements about sexual health which cover four domains: 1) the basic concept of sex; 2) effects of gynecologic cancer treatment on sexual health; 3) effects of gynecologic cancer on sexual health; and 4) management of 0sexual problems. Statements are answered with true, false, or unknown; correct answers = 1; incorrect answers = 0. Total scores range from 0 to 23, with higher scores indicating better sexual knowledge.

    Data were collected at 4 months after intervention.

  • Gynecological Cancer Sexual Knowledge

    The research project assessed changes in gynecological cancer sexual knowledge by Gynecological Cancer Sexual Knowledge(GCSKS) from baseline to 6 months after the intervention. Gynecological Cancer Sexual Knowledge was measured by a 23-item Gynecological Cancer Sexual Knowledge Scale (GCSKS). The GCSKS was designed to assess common conceptions about sexuality after gynecologic cancer treatment (Lee et al., 2020). The 23 items are statements about sexual health which cover four domains: 1) the basic concept of sex; 2) effects of gynecologic cancer treatment on sexual health; 3) effects of gynecologic cancer on sexual health; and 4) management of 0sexual problems. Statements are answered with true, false, or unknown; correct answers = 1; incorrect answers = 0. Total scores range from 0 to 23, with higher scores indicating better sexual knowledge.

    Data were collected at 6 months after intervention.

  • Gynecological Cancer Sexual Attitudes

    The research project assessed changes in gynecological cancer sexual attitudes by Gynecological Cancer Sexual Attitudes Scale (GCSAS) from baseline to 6 months after the intervention. Sexual attitudes were measured with a 25-item Gynecological Cancer Sexual Attitudes Scale (GCSAS) (Lee et al., 2020). The GCSAS measures sexual attitudes or ideas about five areas of sexuality: 1) sexual communication between couples; 2) sexual behavior with partner after gynecologic cancer; 3) perception of body image after cancer treatment; 4) the value of sexual health education; and 5) the impact of sex on the prognosis of gynecologic cancer. Each item is rated on a 5-point Likert-type scale with response options of "do not agree at all" (1) to "totally agree" (5). Total scores range from 25 to 125, with higher scores indicating more positive attitudes towards sex after gynecological cancer treatment.

    Data were collected at baseline.

  • Gynecological Cancer Sexual Attitudes

    The research project assessed changes in gynecological cancer sexual attitudes by Gynecological Cancer Sexual Attitudes Scale (GCSAS) from baseline to 6 months after the intervention. Sexual attitudes were measured with a 25-item Gynecological Cancer Sexual Attitudes Scale (GCSAS) (Lee et al., 2020). The GCSAS measures sexual attitudes or ideas about five areas of sexuality: 1) sexual communication between couples; 2) sexual behavior with partner after gynecologic cancer; 3) perception of body image after cancer treatment; 4) the value of sexual health education; and 5) the impact of sex on the prognosis of gynecologic cancer. Each item is rated on a 5-point Likert-type scale with response options of "do not agree at all" (1) to "totally agree" (5). Total scores range from 25 to 125, with higher scores indicating more positive attitudes towards sex after gynecological cancer treatment.

    Data were collected at 1 week after intervention.

  • Gynecological Cancer Sexual Attitudes

    The research project assessed changes in gynecological cancer sexual attitudes by Gynecological Cancer Sexual Attitudes Scale (GCSAS) from baseline to 6 months after the intervention. Sexual attitudes were measured with a 25-item Gynecological Cancer Sexual Attitudes Scale (GCSAS) (Lee et al., 2020). The GCSAS measures sexual attitudes or ideas about five areas of sexuality: 1) sexual communication between couples; 2) sexual behavior with partner after gynecologic cancer; 3) perception of body image after cancer treatment; 4) the value of sexual health education; and 5) the impact of sex on the prognosis of gynecologic cancer. Each item is rated on a 5-point Likert-type scale with response options of "do not agree at all" (1) to "totally agree" (5). Total scores range from 25 to 125, with higher scores indicating more positive attitudes towards sex after gynecological cancer treatment.

    Data were collected at 6 weeks after intervention.

  • Gynecological Cancer Sexual Attitudes

    The research project assessed changes in gynecological cancer sexual attitudes by Gynecological Cancer Sexual Attitudes Scale (GCSAS) from baseline to 6 months after the intervention. Sexual attitudes were measured with a 25-item Gynecological Cancer Sexual Attitudes Scale (GCSAS) (Lee et al., 2020). The GCSAS measures sexual attitudes or ideas about five areas of sexuality: 1) sexual communication between couples; 2) sexual behavior with partner after gynecologic cancer; 3) perception of body image after cancer treatment; 4) the value of sexual health education; and 5) the impact of sex on the prognosis of gynecologic cancer. Each item is rated on a 5-point Likert-type scale with response options of "do not agree at all" (1) to "totally agree" (5). Total scores range from 25 to 125, with higher scores indicating more positive attitudes towards sex after gynecological cancer treatment.

    Data were collected at 4 months after intervention.

  • Gynecological Cancer Sexual Attitudes

    The research project assessed changes in gynecological cancer sexual attitudes by Gynecological Cancer Sexual Attitudes Scale (GCSAS) from baseline to 6 months after the intervention. Sexual attitudes were measured with a 25-item Gynecological Cancer Sexual Attitudes Scale (GCSAS) (Lee et al., 2020). The GCSAS measures sexual attitudes or ideas about five areas of sexuality: 1) sexual communication between couples; 2) sexual behavior with partner after gynecologic cancer; 3) perception of body image after cancer treatment; 4) the value of sexual health education; and 5) the impact of sex on the prognosis of gynecologic cancer. Each item is rated on a 5-point Likert-type scale with response options of "do not agree at all" (1) to "totally agree" (5). Total scores range from 25 to 125, with higher scores indicating more positive attitudes towards sex after gynecological cancer treatment.

    Data were collected at 6 months after intervention.

  • Gynecological Cancer Sexual self-efficacy

    The research project assessed changes in gynecological cancer sexual self-efficacy by Gynecological Cancer Sexual self-efficacy Scale from baseline to 6 months after the intervention. Cronbach α=0.94。( participants' confidence in their perceived ability to perform healthy postpartum sexual behaviors was measured by the questionnaire's 26-item Postpartum Sexual Self-efficacy subscale , with three dimensions: sexual psychology, sexual biology (e.g., self-care of perineal wound, vaginal lubrication), and sexual communication. Item responses are scored from 0 (no confidence) to 4 (very confident). Higher scores indicate greater confidence in perceived ability to perform a sexual behavior. Total scores range from 0 to 104; internal consistency (alpha coefficient) was 0.94.(Lee \& Yen, 2007)。

    Data were collected at baseline.

  • Gynecological Cancer Sexual self-efficacy

    The research project assessed changes in gynecological cancer sexual self-efficacy by Gynecological Cancer Sexual self-efficacy Scale from baseline to 6 months after the intervention. Cronbach α=0.94。( participants' confidence in their perceived ability to perform healthy postpartum sexual behaviors was measured by the questionnaire's 26-item Postpartum Sexual Self-efficacy subscale , with three dimensions: sexual psychology, sexual biology (e.g., self-care of perineal wound, vaginal lubrication), and sexual communication. Item responses are scored from 0 (no confidence) to 4 (very confident). Higher scores indicate greater confidence in perceived ability to perform a sexual behavior. Total scores range from 0 to 104; internal consistency (alpha coefficient) was 0.94.(Lee \& Yen, 2007)。

    Data were collected at 1 week after intervention.

  • Gynecological Cancer Sexual self-efficacy

    The research project assessed changes in gynecological cancer sexual self-efficacy by Gynecological Cancer Sexual self-efficacy Scale from baseline to 6 months after the intervention. Cronbach α=0.94。( participants' confidence in their perceived ability to perform healthy postpartum sexual behaviors was measured by the questionnaire's 26-item Postpartum Sexual Self-efficacy subscale , with three dimensions: sexual psychology, sexual biology (e.g., self-care of perineal wound, vaginal lubrication), and sexual communication. Item responses are scored from 0 (no confidence) to 4 (very confident). Higher scores indicate greater confidence in perceived ability to perform a sexual behavior. Total scores range from 0 to 104; internal consistency (alpha coefficient) was 0.94.(Lee \& Yen, 2007)。

    Data were collected at 6 weeks after intervention.

  • Gynecological Cancer Sexual self-efficacy

    The research project assessed changes in gynecological cancer sexual self-efficacy by Gynecological Cancer Sexual self-efficacy Scale from baseline to 6 months after the intervention. Cronbach α=0.94。( participants' confidence in their perceived ability to perform healthy postpartum sexual behaviors was measured by the questionnaire's 26-item Postpartum Sexual Self-efficacy subscale , with three dimensions: sexual psychology, sexual biology (e.g., self-care of perineal wound, vaginal lubrication), and sexual communication. Item responses are scored from 0 (no confidence) to 4 (very confident). Higher scores indicate greater confidence in perceived ability to perform a sexual behavior. Total scores range from 0 to 104; internal consistency (alpha coefficient) was 0.94.(Lee \& Yen, 2007)。

    Data were collected at 4 months after intervention.

  • Gynecological Cancer Sexual self-efficacy

    The research project assessed changes in gynecological cancer sexual self-efficacy by Gynecological Cancer Sexual self-efficacy Scale from baseline to 6 months after the intervention. Cronbach α=0.94。( participants' confidence in their perceived ability to perform healthy postpartum sexual behaviors was measured by the questionnaire's 26-item Postpartum Sexual Self-efficacy subscale , with three dimensions: sexual psychology, sexual biology (e.g., self-care of perineal wound, vaginal lubrication), and sexual communication. Item responses are scored from 0 (no confidence) to 4 (very confident). Higher scores indicate greater confidence in perceived ability to perform a sexual behavior. Total scores range from 0 to 104; internal consistency (alpha coefficient) was 0.94.(Lee \& Yen, 2007)。

    Data were collected at 6 months after intervention.

  • Diversity of Sexual Activity

    Diversity of Sexual Activity is the alternative ways of sexual behavior or expression.The 12-item Diversity of Sexual Activities Scale (DSAS)is used to measure the alternative ways of sexual behavior, which includes 1) the occurrence of various sexual behaviors and 2) sexual satisfaction toward the specific sexual behaviors adopted before and after cancer therapy and has been demonstrated to be a valid measure of sexual activity for patients in Taiwan with gynecological cancer(Lee et al., 2020).The first 11 items of the DSAS are 11 sexual activities. Participants are asked to check each sexual activity adopted in the past six months since receiving cancer treatment and rate their satisfaction with the activity on a 7-point Likert scale ranging from 1 (not satisfied at all), 4 (acceptable), to 7 (very satisfied).

    Data were collected at baseline.

  • Diversity of Sexual Activity

    Diversity of Sexual Activity is the alternative ways of sexual behavior or expression.The 12-item Diversity of Sexual Activities Scale (DSAS)is used to measure the alternative ways of sexual behavior, which includes 1) the occurrence of various sexual behaviors and 2) sexual satisfaction toward the specific sexual behaviors adopted before and after cancer therapy and has been demonstrated to be a valid measure of sexual activity for patients in Taiwan with gynecological cancer(Lee et al., 2020).The first 11 items of the DSAS are 11 sexual activities. Participants are asked to check each sexual activity adopted in the past six months since receiving cancer treatment and rate their satisfaction with the activity on a 7-point Likert scale ranging from 1 (not satisfied at all), 4 (acceptable), to 7 (very satisfied).

    Data were collected at 1 week after intervention.

  • Diversity of Sexual Activity

    Diversity of Sexual Activity is the alternative ways of sexual behavior or expression.The 12-item Diversity of Sexual Activities Scale (DSAS)is used to measure the alternative ways of sexual behavior, which includes 1) the occurrence of various sexual behaviors and 2) sexual satisfaction toward the specific sexual behaviors adopted before and after cancer therapy and has been demonstrated to be a valid measure of sexual activity for patients in Taiwan with gynecological cancer(Lee et al., 2020).The first 11 items of the DSAS are 11 sexual activities. Participants are asked to check each sexual activity adopted in the past six months since receiving cancer treatment and rate their satisfaction with the activity on a 7-point Likert scale ranging from 1 (not satisfied at all), 4 (acceptable), to 7 (very satisfied).

    Data were collected at 6 weeks after intervention.

  • Diversity of Sexual Activity

    Diversity of Sexual Activity is the alternative ways of sexual behavior or expression.The 12-item Diversity of Sexual Activities Scale (DSAS)is used to measure the alternative ways of sexual behavior, which includes 1) the occurrence of various sexual behaviors and 2) sexual satisfaction toward the specific sexual behaviors adopted before and after cancer therapy and has been demonstrated to be a valid measure of sexual activity for patients in Taiwan with gynecological cancer(Lee et al., 2020).The first 11 items of the DSAS are 11 sexual activities. Participants are asked to check each sexual activity adopted in the past six months since receiving cancer treatment and rate their satisfaction with the activity on a 7-point Likert scale ranging from 1 (not satisfied at all), 4 (acceptable), to 7 (very satisfied).

    Data were collected at 4 months after intervention.

  • Diversity of Sexual Activity

    Diversity of Sexual Activity is the alternative ways of sexual behavior or expression.The 12-item Diversity of Sexual Activities Scale (DSAS)is used to measure the alternative ways of sexual behavior, which includes 1) the occurrence of various sexual behaviors and 2) sexual satisfaction toward the specific sexual behaviors adopted before and after cancer therapy and has been demonstrated to be a valid measure of sexual activity for patients in Taiwan with gynecological cancer(Lee et al., 2020).The first 11 items of the DSAS are 11 sexual activities. Participants are asked to check each sexual activity adopted in the past six months since receiving cancer treatment and rate their satisfaction with the activity on a 7-point Likert scale ranging from 1 (not satisfied at all), 4 (acceptable), to 7 (very satisfied).

    Data were collected at 6 months after intervention.

Study Arms (2)

The experimental group

EXPERIMENTAL

The experimental group (n=33) received a gender-sensitive and transtheoretical model (TTM)-based sexual health education program, which includes a 10-15-minute individual sexual health education and a sexual health pamphlet. The TTM-based sexual health education program was performed by a nurse educator with more than one year of clinical experience in gynecological nursing, who received formal training through enrollment in a course entitled " a gender-sensitive and transtheoretical model (TTM)-based sexual health education training program."

Behavioral: Received the GS-SHEP

The control group

NO INTERVENTION

The control group (n=30) received a 10-15-minute routine sexual health education and a sexual health pamphlet without a gender-sensitive and theoretically based design. Both were provided by nursing staff with no formal training in " a gender-sensitive and transtheoretical model (TTM)-based sexual health education training program."

Interventions

The experimental group (n=33) received the GS-SHEP (a 10-15-minute individual sexual health education and a sexual health pamphlet). GS-SHEP effectiveness was examined using a self-report instrument to measure background information and three dependent variables: "sexual knowledge," "sexual attitudes," and "sexual self-efficacy."

The experimental group

Eligibility Criteria

Age20 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women were recruited to participant if they were just been diagnosis with cervical cancertment within the previous 1 weeks.
  • to 80 years old.
  • Able to read, write, and speak Chinese.
  • In order to comply with the spirit of gender sensitivity in this study, participants do not exclude whether they have a partner or different sexual orientation.

You may not qualify if:

  • Presence of other malignant disease.
  • Impaired mental function.
  • sexual dysfunction (pre-existing sexual dysfunction may confound the impact of cancer treatment on sexual activity).
  • History of female genital organ surgery before diagnosis of gynecological cancer, or a dependent functional status.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cheng Gung Memorial Hospital

Taoyuan District, Guishan Dist., 333, Taiwan

Location

Related Publications (10)

  • Kau YC, Liu FC, Kuo CF, Huang HJ, Li AH, Hsieh MY, Yu HP. Trend and survival outcome in Taiwan cervical cancer patients: A population-based study. Medicine (Baltimore). 2019 Mar;98(11):e14848. doi: 10.1097/MD.0000000000014848.

    PMID: 30882680BACKGROUND
  • Hung H, You J, Chiang J, Hsieh P, Chiang S, Lai C, Tasi W, Yeh C, Chern Y, Hsu Y. Clinicopathological characteristics and outcomes of metachronous rectal cancer in patients with a history of cervical cancer with and without remote radiotherapy: Reports of 45 cases. Medicine (Baltimore). 2020 Jul 24;99(30):e21328. doi: 10.1097/MD.0000000000021328.

    PMID: 32791729BACKGROUND
  • Donovan KA, Taliaferro LA, Alvarez EM, Jacobsen PB, Roetzheim RG, Wenham RM. Sexual health in women treated for cervical cancer: characteristics and correlates. Gynecol Oncol. 2007 Feb;104(2):428-34. doi: 10.1016/j.ygyno.2006.08.009. Epub 2006 Sep 26.

    PMID: 17005248BACKGROUND
  • Lee J, Lin JB, Sun FJ, Chen YJ, Chang CL, Jan YT, Wu MH. Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience. Medicine (Baltimore). 2017 Mar;96(10):e6158. doi: 10.1097/MD.0000000000006158.

    PMID: 28272204BACKGROUND
  • Guo C, Wang J, Wang Y, Qu X, Shi Z, Meng Y, Qiu J, Hua K. Novel artificial intelligence machine learning approaches to precisely predict survival and site-specific recurrence in cervical cancer: A multi-institutional study. Transl Oncol. 2021 May;14(5):101032. doi: 10.1016/j.tranon.2021.101032. Epub 2021 Feb 20.

    PMID: 33618238BACKGROUND
  • Hogan, R.M. Human sexuality : A nursing perspective. Norwork : Appleton- Century-Crofs.1985.

    BACKGROUND
  • Lee JT, Kuo HY, Huang KG, Lin JR, Chen ML. Diversity of sexual activity and correlates among women with gynecological cancer. Gynecol Oncol. 2020 Nov;159(2):503-508. doi: 10.1016/j.ygyno.2020.08.005. Epub 2020 Aug 27.

    PMID: 32861538BACKGROUND
  • Lee JT, Yen HW. Randomized controlled evaluation of a theory-based postpartum sexual health education programme. J Adv Nurs. 2007 Nov;60(4):389-401. doi: 10.1111/j.1365-2648.2007.04395.x.

    PMID: 17919161BACKGROUND
  • Lee JT, Tsai JL. Transtheoretical model-based postpartum sexual health education program improves women's sexual behaviors and sexual health. J Sex Med. 2012 Apr;9(4):986-96. doi: 10.1111/j.1743-6109.2011.02419.x. Epub 2011 Aug 3.

    PMID: 21812937BACKGROUND
  • Lee, J. T. Bringing Gender Sensitivity into Sexual Health Education Program for Women with Gynecologic Cancer in Taiwan. Ministry of Science and Technology Research Program Report, 2017.Program Number:103-2511-S-182-005-MY2.

    BACKGROUND

MeSH Terms

Conditions

SexualityHealth Education

Condition Hierarchy (Ancestors)

Sexual BehaviorBehaviorAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Study Officials

  • Jian Tao LEE, Professor

    Chang Gung University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: For this two-group, controlled trial, 63 participants with cervical cancer were recruited from the gynecological wards of a large-scale medical center in northern Taiwan. The control group (n=30) received routine sexual health teaching (a 10-15-minute routine individual sexual health education and a sexual health pamphlet without a gender-sensitive and theoretically based design. The experimental group (n=33) received the GS-SHEP (a 10-15-minute individual sexual health education and a sexual health pamphlet).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2023

First Posted

March 16, 2023

Study Start

March 26, 2017

Primary Completion

June 26, 2018

Study Completion

December 26, 2018

Last Updated

March 16, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations